- Conditions
- Nasal Septal Deviation, Nasal Airway Obstruction
- Interventions
- Implantation of Spirair Nasal Device using the Spirair delivery system.
- Device
- Lead sponsor
- Spirair, Inc
- Industry
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 8
- States / cities
- Birmingham, Alabama • Torrance, California • Louisville, Kentucky + 5 more
Source: ClinicalTrials.gov public record
Updated Mar 29, 2026 · Synced May 22, 2026, 1:44 AM EDT